Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Angiotensin Receptor Blockers in the Management of Hypertension: A Real-World Perspective and Current Recommendations
Giovanna Gallo, Massimo Volpe, Speranza Rubattu
Vascular Health and Risk Management (2022) Vol. Volume 18, pp. 507-515
Open Access | Times Cited: 26

Showing 1-25 of 26 citing articles:

2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension
Giuseppe Mancia, Reinhold Kreutz, Mattias Brunström, et al.
Journal of Hypertension (2023) Vol. 41, Iss. 12, pp. 1874-2071
Open Access | Times Cited: 1435
Inflammation, oxidative stress and mitochondrial dysfunction in the progression of type II diabetes mellitus with coexisting hypertension
Hibba Yousef, Ahsan H. Khandoker, Samuel F. Feng, et al.
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 23
Potential Mechanisms of the Protective Effects of the Cardiometabolic Drugs Type-2 Sodium–Glucose Transporter Inhibitors and Glucagon-like Peptide-1 Receptor Agonists in Heart Failure
Giovanna Gallo, Massimo Volpe
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2484-2484
Open Access | Times Cited: 10
Sensational site: the sodium pump ouabain-binding site and its ligands
Mordecai P. Blaustein, John M. Hamlyn
AJP Cell Physiology (2024) Vol. 326, Iss. 4, pp. C1120-C1177
Open Access | Times Cited: 6
The Moreton Lecture Series: The Renin-Angiotensin-Aldosterone System—Physiology, Pathophysiology, and Pharmacological Inhibition
Prem Patel, Jessica Ammon, Sean J. Battle, et al.
Southern Medical Journal (2025) Vol. 118, Iss. 1, pp. 9-13
Closed Access
Recent advances in microneedles for enhanced functional angiogenesis and vascular drug delivery
Ngoc Hong Nguyen, Thuy Trang Nguyen, Vu Khac Hoang Bui, et al.
Therapeutic Delivery (2025), pp. 1-14
Closed Access
Cancer and Cardiovascular Disease: The Conjoined Twins
Mohammad Zmaili, Jafar Alzubi, Motasem Alkhayyat, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1450-1450
Open Access | Times Cited: 4
Is It Still Relevant to Discover New ACE Inhibitors from Natural Products? YES, but Only with Comprehensive Approaches to Address the Patients’ Real Problems: Chronic Dry Cough and Angioedema
Sivananthan Manoharan
Molecules (2023) Vol. 28, Iss. 11, pp. 4532-4532
Open Access | Times Cited: 10
Home blood pressure-lowering effect of esaxerenone versus trichlormethiazide for uncontrolled hypertension: a predefined subanalysis of the EXCITE-HT randomized controlled trial by basal calcium channel blocker versus angiotensin receptor blocker
Kazuomi Kario, Hiroyuki Ohbayashi, Masami Hashimoto, et al.
Hypertension Research (2024)
Open Access | Times Cited: 2
Comparison of the Efficacy and Tolerability of Candesartan Cilexetil between Hypertension patients of Muna and Tolaki Ethnicity
Mesi Leorita, Zullies Ikawati, Agung EndroNugroho, et al.
Research Journal of Pharmacy and Technology (2024), pp. 1503-1509
Closed Access | Times Cited: 1
Comparative efficacy and safety of six angiotensin II receptor blockers in hypertensive patients: a network meta-analysis
Zhi Zhang, Hongxin Yang, Hao Guo
International Journal of Clinical Pharmacy (2024)
Closed Access | Times Cited: 1
The association between ACE inhibitors and psoriasis based on the drug-targeted Mendelian randomization and real-world pharmacovigilance analyses
Qiubai Jin, Feihong Ren, Ping Song
Expert Review of Clinical Pharmacology (2023) Vol. 17, Iss. 1, pp. 93-100
Closed Access | Times Cited: 4
Therapeutical Approach to Arterial Hypertension - Current State of the Art
Milica Radosavljević, Danijela Vučević, Janko Samardžić, et al.
Current Medicinal Chemistry (2024) Vol. 31, Iss. 29, pp. 4602-4620
Closed Access
A systematic review of efficacy and safety for calcium channel blockers in the treatment of albuminuria in patients with diabetes and hypertension
Devanshu J. Patel, Uzma Noor Shah, Shilpa Reddy Ganta, et al.
Multidisciplinary Reviews (2024) Vol. 6, pp. 2023ss004-2023ss004
Open Access
Emerging approaches in secondary hypertension due to renal artery stenosis: evaluation and treatment - systematic review
Mateo Daniel Fabara Vera, Josselyn Nicole Villarreal Enríquez, Jorge D. B. Paladines, et al.
International Journal of Advances in Medicine (2024) Vol. 11, Iss. 3, pp. 223-231
Open Access
Trends in hypertension and hypertension treatment in primary care in general practices in Germany between 2013 and 2022
Karel Kostev, Sarah Krieg, Louis Jacob
Frontiers in Cardiovascular Medicine (2024) Vol. 11
Open Access
Rationale and Design of a Randomized, Open‐Label, Parallel‐Group Study of Esaxerenone Versus Angiotensin Receptor Blockers in Older Patients With Uncontrolled Hypertension on Calcium Channel Blocker Monotherapy (ESCORT‐HT)
Kazuomi Kario, Tomohiro Katsuya, Tatsuo Shimosawa, et al.
Journal of Clinical Hypertension (2024)
Open Access
Topical Losartan for Corneal Fibrosis: A Case Series With Densitometry Analysis
Bárbara Burgos-Blasco, Gregory Moloney
Cornea (2024)
Closed Access
Clinical guidelines of the Russian Medical Society on arterial Hypertension (RSH) and the Eurasian association of Cardiologists (EaC) for the diagnosis and treatment of arterial hypertension (2024)
И Е Чазова, Н М Чихладзе, N. V. Blinova, et al.
Systemic Hypertension (2024) Vol. 21, Iss. 4, pp. 5-110
Open Access
Superior stroke prevention with angiotensin receptor blockers compared with other antihypertensive drugs
Steven G. Chrysant
Expert Opinion on Drug Safety (2023) Vol. 22, Iss. 2, pp. 125-131
Closed Access | Times Cited: 1
Associations of arterial hypertension and the severity of the course of a new coronavirus infection
O. V. Tuzovskaia, N. E. Evdokimova, E. V. Garbuzova, et al.
Ateroscleroz (2023) Vol. 19, Iss. 1, pp. 19-27
Open Access | Times Cited: 1
Network-Based Prediction of Side Effects of Repurposed Antihypertensive Sartans against COVID-19 via Proteome and Drug-Target Interactomes
Despoina P. Kiouri, Charalampos Ntallis, Konstantinos Kelaidonis, et al.
Proteomes (2023) Vol. 11, Iss. 2, pp. 21-21
Open Access | Times Cited: 1
Effects of telmisartan and perindopril combination on hypertension and cardiovascular damage
Do‐Hyung Lee, Youngeun Choi, Seong Pyo Lee, et al.
Journal of Pharmaceutical Investigation (2023) Vol. 53, Iss. 4, pp. 563-570
Closed Access | Times Cited: 1
Hipertensión arterial, un reto farmacológico
Marco Antonio Chalco Moscoso, Alicia Esperanza Zhingre Suárez
Revista Vive (2023) Vol. 6, Iss. 16, pp. 251-263
Open Access
Thermal and degradation study of candesartan under pyrolysis and oxidizing conditions
Laura Teófilo Ferreira, Helena Mannochio-Russo, Guilherme Isquibola, et al.
Journal of Analytical and Applied Pyrolysis (2023) Vol. 173, pp. 106058-106058
Closed Access
Page 1 - Next Page

Scroll to top